| RS2128485171 |
AHI1
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2128489042 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 7, Primary ciliary dyskinesia 7 |
| RS2128490901 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2128492584 |
DNAH11
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 7, Primary ciliary dyskinesia 7 |
| RS2128492914 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2128492930 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 7, Primary ciliary dyskinesia 7 |
| RS2128497316 |
PGM3
|
Health Risk |
Pathogenic |
Immunodeficiency 23, Immunodeficiency 23 |
| RS2128502824 |
TBC1D32
|
Health Risk |
Pathogenic |
— |
| RS2128504331 |
PGM3
|
Health Risk |
Pathogenic |
Immunodeficiency 23, Immunodeficiency 23 |
| RS2128506370 |
PGM3
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency 23, Immunodeficiency 23 |
| RS2128509412 |
PGM3
|
Health Risk |
Pathogenic |
Immunodeficiency 23, Immunodeficiency 23 |
| RS2128522189 |
TBXT
|
Health Risk |
Likely pathogenic |
— |
| RS2128532901 |
INTS1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with cataracts, poor growth |
| RS2128539437 |
INTS1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with cataracts, poor growth |
| RS2128544907 |
INTS1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2128555980 |
EPM2A
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS2128585128 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS2128596101 |
GHRHR
|
Health Risk |
Pathogenic |
Isolated growth hormone deficiency, type 4 |
| RS2128598609 |
GHRHR
|
Health Risk |
Pathogenic |
Isolated growth hormone deficiency, type 4 |
| RS2128599896 |
BMPER
|
Health Risk |
Pathogenic |
Diaphanospondylodysostosis, Diaphanospondylodysostosis |
| RS2128605586 |
ELFN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and Epileptic Encephalopathy with Joint Laxity, DURSUN-OZGUL NEURODEVELOPMENTAL SYNDROME |
| RS2128607933 |
RSPH3
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 32, Primary ciliary dyskinesia 32 |
| RS2128614455 |
EPM2A
|
Health Risk |
Pathogenic |
Myoclonic epilepsy of Lafora 1, Myoclonic epilepsy of Lafora 1 |
| RS2128629356 |
RNF216
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia-hypogonadism syndrome, Cerebellar ataxia-hypogonadism syndrome |
| RS2128632948 |
RNF216
|
Health Risk |
Pathogenic |
— |
| RS2128633891 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2128634170 |
ARID1B
|
Health Risk |
Pathogenic |
ARID1B-related BAFopathy, ARID1B-related BAFopathy |
| RS2128634238 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS2128634414 |
ARID1B
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2128634579 |
ARID1B
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2128637642 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS2128645753 |
RNASET2
|
Health Risk |
Pathogenic |
Cystic leukoencephalopathy without megalencephaly, Cystic leukoencephalopathy without megalencephaly |
| RS2128645761 |
RNASET2
|
Health Risk |
Pathogenic |
Cystic leukoencephalopathy without megalencephaly, Cystic leukoencephalopathy without megalencephaly |
| RS2128646702 |
RNASET2
|
Health Risk |
Likely pathogenic |
Cystic leukoencephalopathy without megalencephaly, Cystic leukoencephalopathy without megalencephaly |
| RS2128646927 |
BBS9
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 9 |
| RS2128649765 |
EPM2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS2128649886 |
EPM2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy, Lafora disease |
| RS2128655278 |
EYA4
|
Health Risk |
Likely pathogenic |
— |
| RS2128656455 |
PMS2
|
Health Risk |
Pathogenic |
Endometrial carcinoma, Endometrial carcinoma |
| RS2128656484 |
PMS2
|
Health Risk |
Pathogenic |
— |
| RS2128657907 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2128658092 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Carcinoma of colon, Hereditary cancer-predisposing syndrome |
| RS2128658183 |
PMS2
|
Health Risk |
Likely pathogenic |
Lynch syndrome 4, Lynch syndrome 4 |
| RS2128658402 |
PMS2
|
Health Risk |
Pathogenic |
— |
| RS2128658792 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2128658900 |
EYA4
|
Health Risk |
Pathogenic |
Nonsyndromic genetic hearing loss, Nonsyndromic genetic hearing loss |
| RS2128659484 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2128665071 |
EYA4
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 10, Autosomal dominant nonsyndromic hearing loss 10 |
| RS2128665075 |
EYA4
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 10, Autosomal dominant nonsyndromic hearing loss 10 |
| RS2128667543 |
BBS9
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 9 |
| RS2128671526 |
PMS2
|
Health Risk |
Pathogenic |
Malignant tumor of breast, Malignant tumor of breast |
| RS2128671557 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colon cancer, Lynch syndrome 4 |
| RS2128672266 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2128672286 |
PMS2
|
Health Risk |
Likely pathogenic |
Malignant tumor of breast, Lynch syndrome 4 |
| RS2128672594 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2128673214 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2128674457 |
EYA4
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1J, Dilated cardiomyopathy 1J |
| RS2128674468 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2128674545 |
EYA4
|
Health Risk |
Likely pathogenic |
— |
| RS2128674870 |
PMS2
|
Health Risk |
Pathogenic |
— |
| RS2128674939 |
EYA4
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 10, Autosomal dominant nonsyndromic hearing loss 10 |
| RS2128674984 |
EYA4
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1J, Ovarian serous cystadenocarcinoma |
| RS2128676082 |
PMS2
|
Health Risk |
Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2128682979 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2128683310 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2128683356 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2128684295 |
PMS2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 4 |
| RS2128702096 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2128704364 |
PMS2
|
Health Risk |
Likely pathogenic |
Lynch syndrome 4, Hereditary cancer-predisposing syndrome |
| RS2128704530 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome |
| RS2128704804 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Greig cephalopolysyndactyly syndrome |
| RS2128704828 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS2128704887 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS2128704900 |
GLI3
|
Health Risk |
Likely pathogenic |
— |
| RS2128704936 |
GLI3
|
Health Risk |
Likely pathogenic |
Polydactyly, postaxial |
| RS2128704974 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Greig cephalopolysyndactyly syndrome |
| RS2128705002 |
GLI3
|
Health Risk |
Likely pathogenic |
— |
| RS2128705010 |
GLI3
|
Health Risk |
Likely pathogenic |
— |
| RS2128705042 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS2128705204 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS2128705420 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Greig cephalopolysyndactyly syndrome |
| RS2128705546 |
GLI3
|
Health Risk |
Likely pathogenic |
— |
| RS2128705596 |
GLI3
|
Health Risk |
Likely pathogenic |
— |
| RS2128705618 |
GLI3
|
Health Risk |
Pathogenic |
GLI3-related disorder, Greig cephalopolysyndactyly syndrome |
| RS2128705693 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS2128706315 |
GLI3
|
Health Risk |
Pathogenic |
Pallister-Hall syndrome, Pallister-Hall syndrome |
| RS2128706319 |
GLI3
|
Health Risk |
Pathogenic/Likely pathogenic |
Polydactyly, postaxial |
| RS2128706417 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS2128707546 |
EYA4
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 10, Autosomal dominant nonsyndromic hearing loss 10 |
| RS2128707619 |
EYA4
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 10, Autosomal dominant nonsyndromic hearing loss 10 |
| RS2128709746 |
TBX20
|
Health Risk |
Pathogenic |
— |
| RS2128709879 |
GLI3
|
Health Risk |
Pathogenic |
Polydactyly, postaxial |
| RS2128709888 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS2128709905 |
GLI3
|
Health Risk |
Pathogenic |
Polydactyly, postaxial |
| RS2128710014 |
GLI3
|
Health Risk |
Pathogenic |
Polydactyly, postaxial |
| RS2128710017 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Polydactyly, postaxial |
| RS2128710024 |
GLI3
|
Health Risk |
Likely pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS2128711268 |
EYA4
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 10, Autosomal dominant nonsyndromic hearing loss 10 |
| RS2128712235 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Greig cephalopolysyndactyly syndrome |
| RS2128712297 |
GLI3
|
Health Risk |
Likely pathogenic |
Polydactyly, postaxial |